M. Burgy

Type de document

Co-auteur

C. Borel

S. Zanetta

M. Wanneveich

M. Velten

A. Thiery

X.S. Sun

C. Sire

J.P. Pignon

A. Pechery

M.A. Onea

G. Noel

C. Mura

M. Masson

S. Martin

C. Macabre

S. Ledrappier

A.C. Jung

A. Jehl

G. Janoray

Y. Hammoud

E. Gherga

S. Foppolo

F. Fasquelle

M. Dontenwill

A. Coutté

O. Conrad

M.P. Chenard

T. Chatellier

H. Burckel

V. Bruban

J. Bourhis

G. Bera

M. Alfonsi

Date

Source

Serveur académique Lausannois (2)

Mot-clé

thérapie (2) cancer (2) survie (2) Treatment (2) Cancer (2) Squamous cell carcinoma (2) Therapeutics (2) Survival (2) Patients (2) Neck (2) Head (2) Cancer (2) Patients (2) toxicité (1) norme (1) solvant (1) risque (1) rayonnement (1) métabolisme (1) anticorps (1) irradiation (1) dose (1) dosage (1) comparaison (1) adulte (1) procès (1) taux (1) Comparison (1) Chemotherapy (1) Care (1)

Documents écrit par M. Burgy (2) | parle de M. Burgy (0)

Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.

C. Borel et al.

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.

M. Burgy et al. (18 juin 2021)